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Human papillomavirus type 5 (HPV 5) induces cutaneous lesions and persists in skin carcinomas of patients with epidermo-
dysplasia verruciformis (EV). We investigated the expression pattern of HPV 5 in biopsies from benign skin lesions of EV
patients by cDNA analysis and in situ hybridization. Nine different cDNAs could be generated from total RNA of one of
these lesions by reverse transcription and PCR amplification with HPV 5-specific primers. We could identify two major
splice donors: one was found in the E6-proximal part of the noncoding region (NCR), and the other just downstream of the
first ATG codon of ORF E1. Each of the characterized transcripts was processed at one or the other donor site and the
two corresponding leader exons were found in combination with both 3*-early and late exons. Two transcripts appear to
be specific for EV-associated papillomaviruses: one species might encode an E1òE2C fusion protein, and the other mRNA
(NCR/E2) is probably encoding for the full-length E2 protein. According to the results of the cDNA analysis, riboprobes
were designed for in situ hybridization experiments to study the cell differentiation-dependent expression of the different
exons. Only the E7/E1 and E4 probes led to strong signals almost throughout the epithelium. The signals generated by the
5*-E2 and E1 probe increased with cell differentiation and were mainly confined to the nucleus. The NCR, E6, E7, L2, and
L1 probes yielded more or less strong signals in the terminally differentiated epidermal layers. The difference in the cell
differentiation-dependent expression of the 5*-early region exon (probe E7/1) and L2/L1 exons may point to a differentiation-
dependent processing of transcripts. q 1995 Academic Press, Inc.
Papillomaviruses represent a very large genus that due to the difficult access to biopsy material and the lack
of cell lines carrying viral DNA. HPV types 8 (15, 16, 17)coevolved with mammals. They achieve efficient dissemi-
and 47 (18) have been investigated for transcript initiationnation by infecting cutaneous and mucosal epithelia,
sites and mRNA structures. Slightly heterogeneous startmildly stimulating proliferation and replicating in termi-
sites were mapped in front of the E6 gene and anothernally differentiated keratinocytes, thereby avoiding major
start site appeared to be located in the E6 coding regionharm to the host. This strategy is reflected by a complex,
upstream of the E7 gene (15, 16, 18). These promotersviral transcription pattern closely linked to the differentia-
are assumed to generate early transcripts. A third pro-tion program of the host cells. Viral gene expression is
moter was mapped in the noncoding region (NCR) ofregulated via promoter activities and RNA processing (1).
HPV 8 (P7535) and the corresponding transcripts wereThe resulting variety of mRNAs was studied in detail for
spliced at an NCR-internal splice donor site (16). Thebovine papillomavirus type 1 (BPV 1) (2, 3), cottontail
map position of this promoter and the processing of therabbit papillomavirus (CRPV) (4, 5), HPV 1 (6), HPV 11 (7),
induced transcripts are reminiscent of late promoters ofHPV 16 (8, 9, 10, 11), and HPV 31 (12, 13).
other skin-specific papillomaviruses (6, 19, 20). Ac-A distinct branch of cutaneous papillomaviruses com-
cording to sequence analysis of viral cDNAs five differentprising more than 15 types preferentially induces skin
mRNA species were disclosed (16, 17, 18).lesions in patients with epidermodysplasia verruciformis
To obtain a more comprehensive picture of the tran-(EV), but related sequences were detected in a large
scriptional pattern of EV-associated HPVs we analyzednumber of skin cancers of immunosuppressed transplant
benign skin lesions of two EV patients which were char-recipients (14). Information on the transcription of EV-
acterized as HPV 5-positive by Southern blot hybridiza-associated HPVs has only emerged in the last few years
tion (data not shown). HPV 5 is most prevalent among
EV patients and closely related to HPV 8 (21). Total RNA
was extracted from an aliquot of one biopsy using the1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 01149/221-407490. Roti-Quick-Kit (Roth, Karlsruhe). HPV 5-specific oligonu-
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TABLE 1 primers and cDNAs were synthesized by PCR using the
different sense primers and the GeneAmpi RNA PCR kitOligonucleotide Primers for cDNA Synthesis and Sequencing
(Perkin–Elmer Cetus, Norwalk) according to manufactur-
er’s instructions (denaturation for 60 sec at 947, primerPrimer Nucleotide position Orientation
annealing for 40 sec at 557, and elongation for 90 sec
NCR 7676 – 7700 S at 727 during 30 cycles). The gel electrophoresis of the
E6 211 – 236 S amplification products showed distinct bands whichE7 662 – 686 S
were identified as HPV 5-positive by Southern blot hybrid-E1 885 – 909 S
ization (data not shown), eventually cloned, and se-5*-E2 3245 – 3269 AS
3*-E2 4243 – 4268 AS quenced. Nine different exon combinations resulting
L2 4510 – 4534 AS from the use of four splice donors and five splice ac-
L1 5988 – 6112 AS ceptors were identified (Figs. 1 and 2). Nearly all the
discovered splice sites were in accord with the estab-Note. The cDNA fragments recovered by reverse transcription and
lished consensus sequences for mammalian splice do-PCR amplification were cloned into the PCR vector (TA Cloning kit,
Invitrogene, San Diego, CA), and positive clones were identified by nors and acceptors (Table 2). Most of the splice sites
colony hybridization and sequenced using the sense (S) or antisense have already been identified for other papillomaviruses,
(AS), HPV 5-specific primers. including the closely related EV-associated HPV 8 and
HPV 47 (2, 4, 6, 7, 8, 12, 16, 17, 18), but we found a
cleotide primers (Table 1) were designed to amplify tran- thereupon unknown internal splice in the E4 ORF in puta-
scripts that were initiated and processed at putative sig- tive L2 messages (D4 and A3, Fig. 1, IV, and Fig. 2) and
nal sequences predicted on the basis of sequence ho- the splice acceptor A4 in the 3*-region of E2 (Fig. 1, VI,
mology among papillomaviruses. One microgram each and Fig. 2). These newly found splice sites all deviate
from the consensus sequences (Table 2). No internal E6of total RNA was reverse transcribed with five antisense
FIG. 1. The main splice sites in HPV 5 mRNAs as deduced from cDNA sequences. The site corresponding to the splice in the mRNA is marked
with an arrow in the sequencing gel. The DNA sequence spanning the splice site is noted. The nucleotide positions of the splice donors (D1–4)
and acceptors (A1–5) are indicated alongside their location in the NCR or the ORFs. Identical results were obtained with independent clones.
/ m4171$7561 11-01-95 09:02:47 viras AP-Virology
247SHORT COMMUNICATION
FIG. 2. HPV 5-specific transcripts and in situ hybridization probes. Part A shows the localization of the exon-specific riboprobes 1 to 9 with the
nucleotide positions of the boundaries. The open reading frames (gray boxes) and NCR are given in part B. The circular genome of HPV 5 is
represented in a linear fashion. The cDNAs recovered from a benign lesion are depicted as black bars in part C. The small arrows indicate the
positions of the primers (Table 1) used to amplify the reverse transcripts by PCR. The thin lines connecting the black bars represent the introns;
the nucleotide positions of the splice donor and acceptor sites are listed above the transcripts and their position is also indicated by the capital
letters D (donor) and A (acceptor) in the genetic map (part B). The coding potentials of the mRNAs, as deduced from the cDNAs, are given to the
right.
splice as shown for the high-risk, genital HPVs (8, 12, the splice acceptor A2 at the beginning of the E4 ORF
at nt 3322, which is highly conserved, and another splice22) could be detected.
The combination of the NCR primer and each of the donor D3 about 150 bp downstream at nt 3468 which
is linked with the splice acceptor A5 (Fig. 1, V) lyingantisense primers resulted in cDNA species a–d (Fig.
2). All of them consist of an exon from the NCR region immediately in front of the ATG of the L1 ORF (nt 5917).
This exon combination was also identified for other cuta-processed at the splice donor site at nt 4 (D1; Fig. 1, I,
II). A similar NCR exon has also been identified for all neous papillomaviruses (6, 16, 19, 20). In contrast to the
two different putative L1 transcripts found for HPV 8 (16),the other cutaneous papillomaviruses investigated so far
(6, 19, 20) and has been found to be characteristic for which differed in the length of their E4 exons, only one
cDNA with a short E4 exon could be amplified with thetranscripts generated by the late promoter. The NCR
exon of HPV 5 is indeed linked to the L1 and L2 exons. L1 primer for HPV 5. With the antisense primer localized
in the 5*-region of the L2 gene and the NCR primer weThe exon combination of NCR/E4/L1 (Fig. 2C, d) utilizes
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TABLE 2
Splice Sites of HPV 5 Transcripts
Splice donor sites Splice acceptor sites
Genomic location nt Sequence Genomic location nt Sequence
D1 (NCR) 4 GCGUAAGU A1 (E2) 2676 UUUACAAGG
D2 (E1) 982 AGGUAGUA A2 (E4) 3322 GUCACCAGC
D3 (E4) 3468 AGGUACGG A3 (E4) 3887 CCGCCCACA
D4 (E4) 3615 ACGUCGCU A4 (E2) 4076 GAGCUAAAA
A5 (L1) 5917 CAUUCGAGA
Mammalian consensus site C/AGGUA/GAGU Mammalian consensus site (Y)nNYAGG
Note. The different splice sites we could identify for HPV 5 mRNAs by sequencing of the amplified cDNAs (Fig. 1) are listed above in comparison
to corresponding consensus splice donor and acceptor sequences found for mammals (30).
recovered a cDNA (Fig. 2C, c) resulting from two splices The primer pair NCR/3*-E2 yielded a cDNA (Fig. 2C,
b) with the NCR exon spliced to the E4 splice acceptorat the NCR donor D1 and the E4 acceptor A2 as well as
at the splice donor D4 in the middle of the E4 gene (nt A2. This exon combination could likewise be identified
for BPV 1 (2) and HPV 1 (6). It has no obvious open3615) and the splice acceptor A3 about 270 bp down-
stream at nt 3887 (Fig. 1, IV). This putative L2 message reading frame and could only encode short peptides.
is thus distinguished from all the other investigated L2 It was remarkable to recover a cDNA (Fig. 2C, a) with
mRNAs of cutaneous papillomaviruses (2, 4, 6) by the the NCR/5*-E2 primer combination in which the D1 donor
internal splice in the E4 ORF. It cannot encode a trun- is connected to the A1 splice acceptor (Fig. 1, I), lying
cated E4 protein as no ATG could be found in the se- shortly upstream of the initiation codon of the E2 ORF at
quence of either the NCR exon or the short E4 exon. nt 2676. This cDNA species might encode a full-length
One may speculate whether this splice leads to a more E2 protein, which acts as a modulator of both viral tran-
efficient initiation of the translation of the L2 ORF. scription and replication (1). The E2 gene is therefore
expected to be transcribed early during the viral life cy-
cle, whereas the NCR exon is so far regarded as a trade-
TABLE 3 mark of the ‘‘late’’ promoter. This raises the question of
Exon-Specific Probes for HPV 5 whether the observed transcript should guarantee some
E2 expression during the late phase of the viral transcrip-
Probe Genomic location nt position Flanking cleavage sites tion or whether the presumed late promoter is also active
at early times. A similar exon combination has so far only1 NCR 7676–1 AatII–HpaI
been identified for HPV 8 (17).2 E6 212–354 NlaIV–HindIII
3 E7 533–706 EcoRV–SacI With the antisense primers in the 5*- and 3*-regions
4 E7/E1 706–966 SacI–BamHI of the E2 ORF paired with each of the three sense primers
5 E1 1364–2215 KpnI–EcoRI
designed to detect transcripts starting upstream of the6 E2 2701–3034 BclI–Eco47III
ORFs E6, E7, and E1 we were able to amplify the cDNA7 E4 3684–4241 PstI–StuI
8 L2 5092–5448 ScaI–BglII species e–j (Fig. 2). All of them result from splices at
9 L1 6095–6450 HindIII–BclI donor site D2 (Fig. 1, III, VI) at the beginning of the E1
ORF (nt 982) and the already described acceptor sites
Note. Appropriate DNA fragments were obtained by digestion of the
in front of the E2 (A1) and in the E4 (A2) ORF. This spliceHPV 5 genome with the listed restriction enzymes and inserted into
donor seems to be a general feature of early transcriptsthe M13/ vector (Vector Cloning Systems, San Diego, CA). The identity
of each clone and the orientation of the insert were confirmed by of all papillomaviruses (4, 6, 7, 10, 12, 18, 19). The cDNA
diagnostic restriction enzyme cleavage or in the case of probe 1 and f (Fig. 2) amplified with the E6/3*-E2 primer pair has al-
2 by sequence analysis. All plasmids were linearized prior to transcrip- ready been described for HPV 47 (18) and all the other
tion. Depending on the choice of the promoter, the in vitro synthesized
investigated papillomaviruses (2, 4, 6, 7, 10, 12), whereasRNAs were either in the same orientation as mRNA (sense) or in the
the cDNA species generated with the E6/5*-E2 primeropposite orientation (antisense). In vitro synthesis in the presence of
35S-UTP was followed by alkaline hydrolysis to reduce the probe length combination (Fig. 2C, e) has so far been identified only
to approximately 300 nt (31). The quality of the transcribed RNAs was for HPV 11 (7) and CRPV (4). The messages captured
tested by acrylamid gel electrophoresis. The shortest probe (no. 1) was
with the E7 and E1 sense primers and 5*-/3*-E2 antisenseapplied at a concentration of 1.9 1 108 cpm/ml hybridization mixture,
primers (Fig. 2C, g–j) were only 5*-shortened versionsand the concentrations of the others were normalized in relation to the
probe length. of the ones amplified with the E6 primer. The transcripts
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FIG. 3. In situ hybridization of a benign cutaneous lesion of an EV patient. The histopathology is shown after hematoxylin and eosin staining (A).
The following sections were hybridized to HPV 5-specific probes (Fig. 2 and Table 3): E4, 7 (B); E7/1, 4 (C); E1, 5 (D); E2, 6 (E); E6, 2 (F); E7, 3 (G);
L1, 9 (H); L2, 8 (I); and NCR, 1 (K). The in situ hybridization was conducted as described by Iftner et al. (32). Bound radioactivity generated dark
silver grains in the film emulsion which appeared after a 10-day exposure. Scale bar, 10 mm.
which gave rise to the described cDNA species might protein, which has been identified for HPV 11 (25) and
which might associate with filaments of the cytoskeletonencode the proteins E6 and E7 with transforming poten-
tial (23, 24) as well as the E2 modulator and the E1òE4 thereby inducing its disintegration (9).
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FIG. 3—Continued
We were also able to amplify cDNAs with the E1 primer exon as described for HPV 11 (7) and HPV 1 (6). The E1/
L2 primer pairing generated a cDNA (Fig. 2C, l) whichand the antisense primers positioned in the late ORFs
L1 and L2 (Fig. 2C, l and m). The E1/L1 amplified cDNA was processed at the E1 donor site D2 and the acceptor
site A2 at the beginning of the E4 ORF and also showed(Fig. 2C, m) was processed like the one generated with
the NCR/L1 primer combination apart from using the E1 the peculiar E4-internal splice (D4/A3), supporting the
findings for the cDNA amplified with the NCR/L2 primerdonor. It consists of a short E4 exon linked to the L1
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FIG. 3—Continued
combination. Unlike the putative L2 message with the shorter than the ones representing the E1òE4 message.
The E1 splice donor D2 turned out to be connected withNCR exon, the latter transcript provides the ATG of the
short E1 exon and might therefore encode a truncated a splice acceptor A4 at nt 4076 (Fig. 1, VI) at the end of
the E2 gene. This cDNA contains an open reading frameE1òE4 protein of unknown function.
One cDNA clone with an insert amplified with the E1/ that could encode an E1òE2C fusion protein, whose
translation would start at the first ATG of E1 and which3*-E2 primer combination (Fig. 2C, k) was considerably
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FIG. 3—Continued
would consist of 6 amino acids of E1 and 63 amino acids larly truncated E2 exon could be found in combination
with a NCR exon in BPV 1 (19). Interestingly, the E1òE2Cof E2. A comparable cDNA species has so far not been
detected for any other HPV type. As we found only one fusion protein would only contain a truncated C-terminus
of E2, which, according to the cocrystallization data ofsuch clone and as the splice acceptor sequence consid-
erably deviates from the consensus, the significance of Hedge et al. (26), should no longer bind DNA but might
retain the ability to dimerize.this finding remains to be established. However, a simi-
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FIG. 3—Continued
In order to investigate the cell differentiation-depen- characteristic for EV (27); the infected parts of the epithe-
lium were clearly distinguishable from the adjacent nor-dent expression of these transcripts in the epithelium of
benign lesions in situ hybridization experiments were mal tissue by enlarged, dysplastic cells already in the
suprabasal layers (Fig. 3A). Serial cryostatic sections ofcarried out. Exon-specific riboprobes were designed ac-
cording to the identified cDNAs (Table 3 and Fig. 2). the biopsy material were hybridized with the subgenomic
antisense and sense 35S-labeled RNA probes. The senseThe biopsies presented cytopathical features considered
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probes only gave rise to background signals. The signal sion of L1 and L2. Similiar promoters located in the
NCR were described for other cutaneous papillomavi-distribution with antisense probes varied largely. In gen-
eral, the amount of viral RNA increased with the degree ruses (3, 5). The NCR exon-specific signals were very
weak in comparison to the L1-specific signals, evenof differentiation of the keratinocytes. No HPV 5-specific
transcripts could be detected in the basal layer. The taking into account the smaller size of the NCR probe.
Combined with the cDNA data this may support thestrongest signals were obtained with the riboprobes
E7/1 and E4 (Figs. 3C and 3B). The stronger ‘‘E4 signal’’ notion that the upstream NCR promoter is not the only
promoter driving expression of structural proteincannot be explained by a significant amount of NCR/E4
transcripts as represented by cDNA b (Fig. 2) because genes. The signal stemming from the E2 probe corre-
lated neither in strength nor in distribution with thethe NCR probe generated only weak signals in the super-
ficial layers (Fig. 3K). The difference in signal intensity signal of the NCR exon. This leader exon therefore
does not seem to be significantly involved in the ex-between the E7/1 and the E4 hybridization may therefore
result from the lower complexity of the E7/1 probe and pression of the E2 gene, but we cannot rule out the
possibility that the NCR promoter serves to transcribecould be accentuated by a start of the transcripts within
ORF E7, further reducing the size of hybridizing se- E2 at a low level.
The different signal strength obtained with the E6quences.
The signals generated by the E1 and E2 probes were probe and the E7 riboprobe, respectively, suggests
that there are two promoters in front of and within thegenerally less abundant than the signals from the
E7/1 and E4 probes and were observed in the upper E6 ORF as has already been described for HPV 8 (15).
Attempts to amplify cDNAs with the E6 primer and antwo-thirds of the tissue (Figs. 3D and 3E). They were
mainly restricted to the nuclei, which may implicate a antisense primer homologous to the 5*-end of E1 failed
to detect an internal E6 splice as described for HPV 16low level of translatable mRNA and E1/E2 proteins. The
overall signals obtained with the E2 riboprobe were (8). EV-associated viruses thus seem to use a similar
strategy for the expression of the E6/E7 region as thesignificantly stronger than the ones obtained with the
E1 probe. ‘‘low-risk’’ genital HPVs. As the signal received with the
E7/1 probe was considerably stronger than the oneThe E6- and E7-specific riboprobes detecting tran-
scripts of the viral oncogenes were just detectable with the E7 riboprobe (Figs. 3C and 3G), we postulate
the existence of another promoter within the E7 gene.within single cells in the most superficial layers (Figs.
3F and 3G). This transcription pattern of E6/E7 is remi- Such a promoter has already been mapped for the
genital HPV 31b (12). The remarkable signal strengthniscent of the one found in benign, HPV 16-infected
biopsy material (28). The results do not exclude E6/ observed with the E7/1 riboprobe indicates a rather
strong activity of this promoter. Based on the cDNAE7 expression below the sensitivity levels of in situ
hybridization in basal and suprabasal layers but sug- analysis it is probably not only responsible for the
abundant E1òE4 message (cDNA j, Fig. 2) and thegest a tight control, which makes sense in the case of
highly oncogenic HPVs with regard to a persistent vi- lion’s share of the E2 expression (cDNA i, Fig. 2) but
may also play a major role in generating late tran-rus – host coexistence. Overexpression of the onco-
genes might rapidly lead to carcinomas, which are scripts (cDNA l and m, Fig. 2). Similar to HPV 31, early
and late mRNAs thus could be partially expressed fromnon-virion-producing dead-end streets.
Transcripts of the structural genes were only detected the same promoter. As in situ hybridization showed
clear differences in the localization of 3*-early and latein the superficial layers (Figs. 3H and 3I). The signals
obtained with the L1 and L2 riboprobes were mostly exons one would have to assume a cell differentiation-
dependent control of RNA processing, which has re-found in the cytoplasm and were evenly distributed
throughout the stratum granulosum. The signal gener- cently been established for HPV 31 (13).
ated by the L2 probe was definitely weaker than the one
obtained with the L1 probe, which is in line with L2 and ACKNOWLEDGMENTS
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